We are live on ! Find out more
GMED icon

Globus Medical

244 hedge funds and large institutions have $2.11B invested in Globus Medical in 2017 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 105 increasing their positions, 76 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

715% more call options, than puts

Call options by funds: $701K | Put options by funds: $86K

38% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 76

7% more capital invested

Capital invested by funds: $1.97B → $2.11B (+$146M)

10% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 31

0% more funds holding

Funds holding: 243244 (+1)

3.84% less ownership

Funds ownership: 92.38%88.54% (-3.8%)

57% less funds holding in top 10

Funds holding in top 10: 73 (-4)

Holders
244
Holders Change
+1
Holders Change %
+0.41%
% of All Funds
6.08%
Holding in Top 10
3
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-57.14%
% of All Funds
0.07%
New
34
Increased
105
Reduced
76
Closed
31
Calls
$701K
Puts
$86K
Net Calls
+$615K
Net Calls Change
-$2.04M
Name Holding Trade Value Shares
Change
Change in
Stake
SG Americas Securities
101
SG Americas Securities
New York
$1.59M +$249K +7,937 +20%
Barclays
102
Barclays
United Kingdom
$1.58M +$963K +30,655 +182%
GA
103
Geneva Advisors
Illinois
$1.51M +$44.4K +1,413 +3%
Canada Life
104
Canada Life
Manitoba, Canada
$1.46M +$67.7K +2,155 +5%
Invesco
105
Invesco
Georgia
$1.44M +$19.9K +633 +1%
MAM
106
Martingale Asset Management
Massachusetts
$1.41M +$176K +5,600 +15%
Susquehanna International Group
107
Susquehanna International Group
Pennsylvania
$1.39M +$1.02M +32,621 +353%
BG
108
Bellevue Group
Switzerland
$1.33M
BNP Paribas Financial Markets
109
BNP Paribas Financial Markets
France
$1.3M +$631K +20,076 +104%
US Bancorp
110
US Bancorp
Minnesota
$1.27M -$112K -3,551 -8%
AL
111
AJO LP
Pennsylvania
$1.26M +$1.2M +38,068 New
Citadel Advisors
112
Citadel Advisors
Florida
$1.26M -$11.8M -374,813 -91%
BCC
113
Bridge City Capital
Oregon
$1.24M +$1.18M +37,511 New
Millennium Management
114
Millennium Management
New York
$1.22M +$1.16M +36,833 New
MSA
115
Mason Street Advisors
Wisconsin
$1.17M +$40.5K +1,291 +4%
AG
116
Aperio Group
California
$1.13M +$610K +19,437 +132%
WSFS
117
Wilmington Savings Fund Society
Delaware
$1.13M
Federated Hermes
118
Federated Hermes
Pennsylvania
$1.09M -$235K -7,473 -19%
VOYA Investment Management
119
VOYA Investment Management
Georgia
$1.08M +$191K +6,073 +23%
CIA
120
Capital Impact Advisors
Massachusetts
$1.05M -$381K -12,126 -28%
SBIA
121
Sheaff Brock Investment Advisors
Indiana
$1.03M
ASRS
122
Arizona State Retirement System
Arizona
$1.01M +$15.7K +500 +2%
SOMRS
123
State of Michigan Retirement System
Michigan
$988K +$18.8K +600 +2%
LMGAM
124
Liberty Mutual Group Asset Management
Massachusetts
$982K -$92.5K -2,946 -9%
First Trust Advisors
125
First Trust Advisors
Illinois
$972K +$678K +21,602 +279%

GMED Hedge Fund Activity: Q2 2017 in Review

244 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2017, worth a combined $2.11B — up 7.4% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new GMED positions and 31 closed out — a net gain of 3 holders — while 105 added to existing stakes and 76 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $60.9M. The largest seller was Wellington Management Group, cutting an estimated $44.1M.

  • 244 institutional investors held Globus Medical (GMED) as of Q2 2017, up from 243 in Q1 2017.
  • Funds reported $2.11B of Globus Medical stock for Q2 2017, up 7.4% quarter-over-quarter.
  • 34 funds opened new Globus Medical positions in Q2 2017 and 31 closed out, a net change of +3 holders.
  • The largest Globus Medical buyer in Q2 2017 was Janus Henderson Group, an estimated $60.9M added.
  • The largest Globus Medical seller in Q2 2017 was Wellington Management Group, an estimated $44.1M sold.

Based on aggregated 13F filings for Q2 2017.